Moderna (MRNA) Announces Proposed $1.25 Billion Public Offering of Shares of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Moderna (MRNA) Announces Proposed $1.25 Billion Public Offering of Shares of Common Stock
May 19, 2020 5:47 AM EDT
Moderna, Inc. (NASDAQ: MRNA) today announced the pricing of an underwritten public offering of 17,600,000 shares of common stock at a public offering price of $76.00 per share, before underwriting discounts and commissions. In addition, Moderna has granted the underwriters a 30-day option to purchase up to... More
May 18, 2020 4:23 PM EDT
Moderna (NASDAQ: MRNA) is Said to Offer Shares at $75 to $77.50 Each - Bloomberg
...
More
May 18, 2020 7:31 AM EDT
Moderna, Inc., (Nasdaq: MRNA) announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Immunogenicity data are currently available for the 25 µg and 100 µg dose level (ages 18-55) after two doses (day 43) and at the 250 µg level (ages 18-55) after one dose (day 29). Dose dependent increases in immunogenicity were seen across the three dose levels, and between prime and boost within the 25 µg and 100 µg... More
